Related Experiment Video
Updated: May 16, 2025

05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.1K
FGLFA: A Federated Graph Learning-based Cross-Network Layer Feature Alignment Model for Major Depressive Disorder
IEEE Journal of Biomedical and Health Informatics
|April 2, 2025
Summary
Federated Graph Learning addresses major depressive disorder (MDD) identification challenges by aligning data across sites. This novel approach improves diagnostic accuracy and offers a more efficient tool for early brain disease treatment.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Informatics
Background:
- Centralizing medical datasets for major depressive disorder (MDD) research is hindered by privacy, security, and storage concerns.
- Federated Learning (FL) enables collaborative model training without data centralization but often struggles with data heterogeneity across different sites.
Purpose of the Study:
- To propose a Federated Graph Learning-based Cross-Network Layer Feature Alignment (FGLFA) model for improved MDD identification.
- To address the challenge of data heterogeneity in federated learning for medical datasets.
Main Methods:
- The FGLFA model utilizes Graph Sampling and Aggregation (GraphSAGE) networks trained independently at each site to extract graph-structured features.
- Residual connections (RCs) are integrated into the GraphSAGE networks to mitigate gradient vanishing and accelerate convergence.
- A feature alignment module is employed to harmonize cross-network layer features, reducing distribution discrepancies between sites.
Main Results:
- The FGLFA model achieved an average accuracy (ACC) of 65.1% and an F1-score of 70.9% across three independent sites.
- The proposed method demonstrated consistent advantages over mainstream federated paradigms, reducing variance by 23% and enhancing MDD identification accuracy.
Conclusions:
- The FGLFA model offers an effective solution for privacy-preserving, collaborative MDD identification.
- This approach provides a more efficient tool for the early diagnosis and treatment of brain diseases, overcoming data heterogeneity issues.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
22
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
22
Depressive Disorders: Etiology
25
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
25
Depression: Overview
201
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
201

